IL162932A0 - Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 - Google Patents

Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2

Info

Publication number: IL162932A0
Authority: IL; Israel
Prior art keywords: cyclooxygenase; alpha; combinations; selective inhibitor; delta ligand
Prior art date: 2002-02-22

Application number

IL16293203A

Other languages

English (en)

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-22

Filing date

2003-02-12

Publication date

2005-11-20

2003-02-12 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2005-11-20 Publication of IL162932A0 publication Critical patent/IL162932A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL16293203A 2002-02-22 2003-02-12 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 IL162932A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US35929502P	2002-02-22	2002-02-22
US40436502P	2002-08-19	2002-08-19
PCT/IB2003/000534 WO2003070237A1 (en)	2002-02-22	2003-02-12	Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2

Publications (1)

Publication Number	Publication Date
IL162932A0 true IL162932A0 (en)	2005-11-20

Family

ID=27760521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16293203A IL162932A0 (en)	2002-02-22	2003-02-12	Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2

Country Status (21)

Country	Link
US (1)	US20030199567A1 (es)
EP (1)	EP1480639A1 (es)
JP (1)	JP2005523281A (es)
KR (1)	KR20040085216A (es)
CN (1)	CN1635887A (es)
AR (1)	AR038531A1 (es)
AU (1)	AU2003246864A1 (es)
BR (1)	BR0307906A (es)
CA (1)	CA2476438A1 (es)
CO (1)	CO5611109A2 (es)
HN (1)	HN2003000071A (es)
IL (1)	IL162932A0 (es)
MX (1)	MXPA04008175A (es)
NO (1)	NO20043947L (es)
PA (1)	PA8567201A1 (es)
PE (1)	PE20031052A1 (es)
PL (1)	PL372210A1 (es)
RU (1)	RU2286151C2 (es)
TW (1)	TW200303214A (es)
UY (1)	UY27675A1 (es)
WO (1)	WO2003070237A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2196201A3 (en) *	2002-12-13	2010-12-08	Warner-Lambert Company LLC	Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms
WO2004084881A1 (en) *	2003-03-21	2004-10-07	Dynogen Pharmaceuticals, Inc.	METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
PL378583A1 (pl) *	2003-03-21	2006-05-02	Dynogen Pharmaceuticals, Inc.	Sposoby leczenia zaburzeń dolnych dróg układu moczowego z zastosowaniem modulatorów mięśni gładkich i modulatorów podjednostki Ó2Ű kanałów wapniowych
US20060264509A1 (en) *	2003-03-21	2006-11-23	Fraser Matthew O	Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators
US7169812B2 (en)	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
ATE449633T1 (de) *	2003-09-12	2009-12-15	Pfizer	Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
GB0322140D0 (en) *	2003-09-22	2003-10-22	Pfizer Ltd	Combinations
WO2005041976A2 (en) *	2003-10-23	2005-05-12	Medtronic, Inc.	Injectable gabapentin compositions
CL2007001006A1 (es) *	2006-04-11	2008-07-11	Novartis Ag	Compuestos derivados de piperidina u 8-aza-biciclo[3.2.1]octano sustituidos; formulacion farmaceutica; producto; y uso para el tratamiento o prevencion de enfermedades tales como diabetes mellitus no insulino dependiente, artritis, obesidad, dislipid
BRPI0718874A2 (pt) *	2006-12-22	2015-06-23	Novartis Ag	Compostos orgânicos
EP2286224A4 (en) *	2008-05-05	2012-04-25	Univ Winthrop Hospital	METHOD FOR IMPROVING THE CARDIOVASCULAR RISK PROFILE OF COX-INHIBITORS
TR201904388T4 (tr) *	2008-09-05	2019-05-21	Gruenenthal Gmbh	Pregabalin veya gabapentin ve 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolün farmasötik kombinasyonu.
KR102631399B1 (ko) *	2018-03-30	2024-02-01	씨지인바이츠 주식회사	폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
KR20230118081A (ko) *	2020-10-28	2023-08-10	트루모 파마슈티칼스, 인크.	수불용성 cox-2 억제제의 수성 제형

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5234929A (en) *	1992-07-20	1993-08-10	William Chelen	Method of treating motion sickness with anticonvulsants and antitussive agents
US5321012A (en) *	1993-01-28	1994-06-14	Virginia Commonwealth University Medical College	Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5420270A (en) *	1993-10-07	1995-05-30	G. D. Searle & Co.	Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5466823A (en) *	1993-11-30	1995-11-14	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides
US5352638A (en) *	1994-02-22	1994-10-04	Corning Incorporated	Nickel aluminosilicate glass-ceramics
DK0804182T3 (da) *	1994-07-27	2002-09-09	Warner Lambert Co	Anvendelse af gabapentin ved behandling af angst og panik
US5633272A (en) *	1995-02-13	1997-05-27	Talley; John J.	Substituted isoxazoles for the treatment of inflammation
WO1999008670A1 (en) *	1997-08-20	1999-02-25	Guglietta, Antonio	Gaba analogs to prevent and treat gastrointestinal damage
BR9812162A (pt) *	1997-09-08	2000-07-18	Warner Lambert Co	Composições analgésicas compreendendo compostos antiepiléticos e métodos para o uso das mesmas
NZ503980A (en) *	1997-12-16	2002-09-27	Warner Lambert Co	4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders
AU3216600A (en) *	1999-03-10	2000-09-28	Warner-Lambert Company	Analgesic compositions comprising anti-epileptic compounds and methods of using same
HN2000000224A (es) *	1999-10-20	2001-04-11	Warner Lambert Co	Aminoacidos biciclicos como agentes farmaceuticos
GB9927844D0 (en) *	1999-11-26	2000-01-26	Glaxo Group Ltd	Chemical compounds
HRP20010582A2 (en) *	1999-12-08	2002-08-31	Pharmacia Corp	Valdecoxib compositions

2003
- 2003-02-12 WO PCT/IB2003/000534 patent/WO2003070237A1/en not_active Ceased
- 2003-02-12 MX MXPA04008175A patent/MXPA04008175A/es unknown
- 2003-02-12 JP JP2003569193A patent/JP2005523281A/ja not_active Abandoned
- 2003-02-12 BR BR0307906-6A patent/BR0307906A/pt not_active IP Right Cessation
- 2003-02-12 IL IL16293203A patent/IL162932A0/xx unknown
- 2003-02-12 PL PL03372210A patent/PL372210A1/xx not_active Application Discontinuation
- 2003-02-12 EP EP03742460A patent/EP1480639A1/en not_active Withdrawn
- 2003-02-12 AU AU2003246864A patent/AU2003246864A1/en not_active Abandoned
- 2003-02-12 KR KR10-2004-7013032A patent/KR20040085216A/ko not_active Ceased
- 2003-02-12 RU RU2004125609/15A patent/RU2286151C2/ru not_active IP Right Cessation
- 2003-02-12 CA CA002476438A patent/CA2476438A1/en not_active Abandoned
- 2003-02-12 CN CNA038043564A patent/CN1635887A/zh active Pending
- 2003-02-14 US US10/366,798 patent/US20030199567A1/en not_active Abandoned
- 2003-02-17 PE PE2003000166A patent/PE20031052A1/es not_active Application Discontinuation
- 2003-02-19 UY UY27675A patent/UY27675A1/es not_active Application Discontinuation
- 2003-02-20 AR ARP030100547A patent/AR038531A1/es unknown
- 2003-02-21 TW TW092103596A patent/TW200303214A/zh unknown
- 2003-02-21 HN HN2003000071A patent/HN2003000071A/es unknown
- 2003-02-21 PA PA20038567201A patent/PA8567201A1/es unknown
2004
- 2004-08-13 CO CO04079024A patent/CO5611109A2/es not_active Application Discontinuation
- 2004-09-21 NO NO20043947A patent/NO20043947L/no unknown

Also Published As

Publication number	Publication date
TW200303214A (en)	2003-09-01
EP1480639A1 (en)	2004-12-01
RU2004125609A (ru)	2006-01-27
BR0307906A (pt)	2004-12-21
US20030199567A1 (en)	2003-10-23
UY27675A1 (es)	2003-09-30
CN1635887A (zh)	2005-07-06
AU2003246864A1 (en)	2003-09-09
PE20031052A1 (es)	2003-12-24
PL372210A1 (en)	2005-07-11
JP2005523281A (ja)	2005-08-04
RU2286151C2 (ru)	2006-10-27
NO20043947L (no)	2004-09-21
KR20040085216A (ko)	2004-10-07
PA8567201A1 (es)	2003-11-12
CA2476438A1 (en)	2003-08-28
WO2003070237A1 (en)	2003-08-28
CO5611109A2 (es)	2006-02-28
HN2003000071A (es)	2003-11-24
AR038531A1 (es)	2005-01-19
MXPA04008175A (es)	2004-11-26

Publication	Publication Date	Title
IL162932A0 (en)	2005-11-20	Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
HUP0600294A2 (en)	2007-02-28	Skin-permeable selective cyclooxygenase-2 inhibitor composition
GB0618535D0 (en)	2006-11-08	A solution of metal-polymer chelate(s) and applications thereof
AU2003278039A1 (en)	2004-05-13	Nitric oxide releasing selective cyclooxygenase-2 inhibitors
AU2003238042A1 (en)	2004-01-06	Cyclooxygenase-2 inhibitors
PL374279A1 (en)	2005-10-03	Nitrooxyderivatives of cyclooxygenase-2 inhibitors
AU2003221230A1 (en)	2003-10-13	New methionine aminopeptidase inhibitor
GB0307401D0 (en)	2003-05-07	A fastener
GB0212003D0 (en)	2002-07-03	Seabed anchor
HUP0600235A3 (en)	2008-04-28	Combinations comprising a selective cyclooxygenase-2 inhibitor
AU2003287733A1 (en)	2004-06-18	Selective cyclooxygenase-2 inhibitor patch
PL373523A1 (en)	2005-09-05	Indol-2-ones as selective inhibitors of cyclooxygenase-2
EP1656936A4 (en)	2010-03-17	Macrophage activation INHIBITORS
PL1680635T3 (pl)	2013-08-30	Lodówka
ZA200607990B (en)	2009-03-25	A solution of metal-polymer chelate(s) and applications thereof
AU2003303625A8 (en)	2004-07-29	Combination of reboxetine and a cyclooxygenase-2 inhibitor
AU2002367951A8 (en)	2003-12-02	The use of the inhibitor transmitter of gamma-aminobutyric acid (gaba) in the manufacture of analgesic
IL176473A0 (en)	2006-10-05	Neutrophilia inhibitor
GB0219365D0 (en)	2002-09-25	A vice
PL113009U1 (en)	2003-08-25	Maritime launcher
GB0226207D0 (en)	2002-12-18	Yum Yum
GB0305525D0 (en)	2003-04-16	Inhibitor based sequencing technology
AU2945P (en)	2005-12-05	Exciting Love Anthurium andraeanum
AU2943P (en)	2005-12-05	Red Love Anthurium andraeanum
GB0221244D0 (en)	2002-10-23	Quick shift trigger